Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence

NCT03694249 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Malignant Solid Tumor

Interventions

DRUG: Ifetroban Sodium
OTHER: Placebo

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]